Paper Details

  1. Home
  2. Paper Details

[Economic evaluation of acute migraine attack treatment with triptans in Spain].

Author: González GarciaP, Gracia-NayaM, Latorre JiménezA, Rejas GutiérrezJ

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Eletriptan 40 mg was the most cost-effective triptan among those studied for migraine attack treatment.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To perform an economic evaluation of migraine attack treatment comparing standard doses of existing triptans in 2003, and using different outcome measurements of anti-migraine effectiveness. METHODS: A cost-effectiveness analysis was performed from the National Health System perspective,...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/15815947

データ提供：米国国立医学図書館（NLM）

Triptans: A Cost-Effective Approach to Migraine Treatment

Migraine, a debilitating condition, often leaves individuals seeking effective and affordable treatment options. This research explores the cost-effectiveness of triptans, a class of medications commonly used to treat migraine attacks. The study meticulously compares the cost-effectiveness of various triptans, evaluating their effectiveness in relieving migraine pain and their associated costs. Imagine this research as a careful exploration of a vast desert of migraine treatments, seeking the most effective and affordable path to relief.

The study found that eletriptan 40 mg emerged as the most cost-effective triptan in a majority of the economic analyses. The study carefully considered various factors, such as the duration of pain relief, the need for rescue medication, and the rate of attack relapse. These findings provide valuable insights for healthcare providers and payers seeking to optimize migraine treatment strategies.

Triptans: A Cost-Effective Solution for Migraine Relief

This research highlights the potential of triptans as a cost-effective and effective treatment option for migraine attacks. The study's findings provide valuable information for healthcare providers and payers seeking to optimize migraine treatment strategies and ensure access to affordable and effective care.

Navigating the Desert of Migraine: Finding the Right Path

The desert of migraine can be a difficult landscape to navigate, leaving individuals seeking relief from debilitating pain. This research offers a valuable guide, highlighting the cost-effectiveness of triptans as a treatment option. The study's findings provide valuable insights for healthcare providers and patients alike, enabling them to make informed decisions about migraine treatment and ensure access to affordable and effective care.

Dr. Camel's Conclusion

This research provides compelling evidence for the cost-effectiveness of triptans as a migraine treatment option, offering a valuable resource for healthcare providers and patients seeking to optimize migraine management strategies.

Date :
  1. Date Completed 2006-01-19
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

15815947

DOI: Digital Object Identifier

51090124

Related Literature

Article Analysis
・Effective treatment of migraine
SNS
PICO Info
in preparation
Languages

Spanish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.